Practical Framework for Managing Anticoagulant-Associated Bleeding
A contemporary narrative review consolidating bleeding risk stratification, severity assessment, reversal strategy, and anticoagulation resumption for cardiology and anticoagulation pharmacists.
Bleeding risks complicate anticoagulant therapy management in cardiovascular patients.
Managing bleeding in patients on anticoagulant therapy is crucial due to its high association with morbidity and mortality. The article provides patient-centered flowcharts for acute bleeding management and safe anticoagulation resumption. Highlights the need for individualized anticoagulant regimens and access to reversal agents; emphasizes risk versus benefit balance. Balancing thrombotic and bleeding risks is essential in anticoagulant therapy management.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Authors:Galli M, Simeone B, Ten Berg J, Capodanno D, Valgimigli M, Sciarretta S, Greco E, Kastrati A, Montalescot G, Gibson CM, Gorog DA, Mehran R, Angiolillo DJ
Citation:Galli M, Simeone B, Ten Berg J, et al. Managing bleeds on anticoagulant therapy: a practical guide for clinicians. European heart journal. Acute cardiovascular care. 2026;15(7):557-572. doi:10.1093/ehjacc/zuag035
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.